PDL BioPharma (Nasdaq: PDLI) and Alexion Pharmaceuticals (Nasdaq: ALXN) jointly announced that the companies have entered into a definitive license ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE